Artificial Intelligence: An Emerging Tool for Studying Drug‐Induced Liver Injury
Liver International · 2025-03 · 45 (3)
DOI: 10.1111/liv.70038 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Liver International, online erschienen am 21.02.2025. Verfasst von Hao Niu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Servicios de Aparato Digestivo y Farmacología Clínica, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y…. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Artificial Intelligence. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Instituto de Salud Carlos III, Consejería de Conocimiento, Investigación y Universidad, Junta de Andalucía.
Abstract (Originalsprache)
Drug‐induced liver injury (DILI) is a complex and potentially severe adverse reaction to drugs, herbal products or dietary supplements. DILI can mimic other liver diseases clinical presentation, and currently lacks specific diagnostic biomarkers, which hinders its diagnosis. In some cases, DILI may progress to acute liver failure. Given its public health risk, novel methodologies to enhance the understanding of DILI are crucial. Recently, the increasing availability of larger datasets has highlighted artificial intelligence (AI) as a powerful tool to construct complex models. In this review, we summarise the evidence about the use of AI in DILI research, explaining fundamental AI concepts and its subfields. We present findings from AI‐based approaches in DILI investigations for risk stratification, prognostic evaluation and causality assessment and discuss the adoption of natural language processing (NLP) and large language models (LLM) in the clinical setting. Finally, we explore future perspectives and challenges in utilising AI for DILI research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Servicios de Aparato Digestivo y Farmacología Clínica, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Universidad de M…
- Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain.
- Plataforma de Investigación Clínica y Ensayos Clínicos IBIMA, Plataforma ISCIII de Investigación Clínica, SCReN, Madrid, Spain.
- Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas, USA.
ORCID-Profile: Hao Niu, Ismael Alvarez-Alvarez, Minjun Chen
Förderung
- Instituto de Salud Carlos III
- Consejería de Conocimiento, Investigación y Universidad, Junta de Andalucía
Zitieren
APA
Niu, H., Alvarez-Alvarez, I., & Chen, M. (2025). Artificial Intelligence: An Emerging Tool for Studying Drug‐Induced Liver Injury. Liver International, 45(3). https://doi.org/10.1111/liv.70038
Vancouver
Niu H, Alvarez-Alvarez I, Chen M. Artificial Intelligence: An Emerging Tool for Studying Drug‐Induced Liver Injury. Liver International. 2025;45(3). doi:10.1111/liv.70038
BibTeX
@article{Niu2025,
author = {Niu, Hao and Alvarez-Alvarez, Ismael and Chen, Minjun},
title = {Artificial Intelligence: An Emerging Tool for Studying Drug‐Induced Liver Injury},
journal = {Liver International},
year = {2025},
volume = {45},
number = {3},
doi = {10.1111/liv.70038}
}
EUVIMED